---
title: "Maplight Therapeutics director Martin Babler files initial beneficial ownership statement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290883587.md"
description: "MapLight Therapeutics director Martin Babler filed an initial Form 3 beneficial ownership statement dated June 23. The disclosure was published via EDGAR on June 25, 2026."
datetime: "2026-06-25T21:47:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290883587.md)
  - [en](https://longbridge.com/en/news/290883587.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290883587.md)
---

# Maplight Therapeutics director Martin Babler files initial beneficial ownership statement

-   MapLight Therapeutics director Martin Babler filed an initial Form 3 statement dated June 23. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001435618-26-000009), on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MPLT.US](https://longbridge.com/en/quote/MPLT.US.md)

## Related News & Research

- [Maplight Therapeutics director Troy Cox reports purchase of 15,620 shares worth $148,702.4](https://longbridge.com/en/news/294132686.md)
- [MapLight says Phase 2 ZEPHYR trial shows ML-007C-MA cuts PANSS score in schizophrenia](https://longbridge.com/en/news/293920685.md)
- [FreeCast files Form 3 initial beneficial ownership statement for director Eric William John Seidel](https://longbridge.com/en/news/294238285.md)
- [60 Degrees Pharmaceuticals files Form 3 showing Knight Therapeutics stake of 658,629 shares](https://longbridge.com/en/news/294253182.md)
- [NextCure files Form 3 initial beneficial ownership statement for ADAR1 Capital Management](https://longbridge.com/en/news/294268325.md)